Skip to content

Evaluation of Vitamin D Status in Children With Acute Burns

Vitamin D Deficiency in Acutely Injured Pediatric Burn Patients: Incidence, Etiology, Metabolic Sequelae and Prevention

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00536276
Acronym
VitaminD
Enrollment
50
Registered
2007-09-27
Start date
2003-03-31
Completion date
2011-04-30
Last updated
2012-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns, Bone Demineralization

Keywords

vitamin D

Brief summary

To see which vitamin D supplement (D2 vs D3) is most beneficial in burned children.

Detailed description

The purpose of this study is to follow up our descriptive observations with a prospective randomized double blinded study to verify our clinical perception that hypovitaminosis D is prevalent postburn and to evaluate whether therapeutic supplementation will enhance specific primary outcome measures during burn convalescence.

Interventions

DIETARY_SUPPLEMENTVitamin D2

Daily enteral dose of 100IU/kg

DIETARY_SUPPLEMENTVitamin D3

Daily enteral dose of 100IU/kg

Sponsors

Shriners Hospitals for Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Child is \> 6 months of age but \< 19 years old * Burn injury \> 30% total body surface area * Admitted to SHC within 4 days of injury * Attending physician decision that patient is likely to survive * Parents or legal guardian give informed consent along with assent of the child as applicable

Exclusion criteria

* Attending physician decision that patient is not likely to survive * Prior history of anticonvulsant or glucocorticoid use, gastric/bowel resection, parathyroid disease, liver disease, chronic renal failure or prior pharmacologic vitamin D use (\>1000 IU/D)

Design outcomes

Primary

MeasureTime frame
Examine the effect of D2 vs D3 supplementation on serum 25-OH and 1,25 OH vitamin D levelsDuring acute phase postburn

Secondary

MeasureTime frame
Identify the most efficacious vitamin D analogue in terms of preventing deterioration of bone markersDuring acute phase postburn

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026